202 related articles for article (PubMed ID: 21178721)
1. Summary of presentations from the 46th Annual Meeting of the American Society of Clinical Oncology: focus on non-small cell lung cancer (2010).
Stinchcombe TE; Baggstrom MQ; Somaiah N; Simon GR; Govindan R
J Thorac Oncol; 2011 Jan; 6(1):227-32. PubMed ID: 21178721
[TBL] [Abstract][Full Text] [Related]
2. Summary of presentations from the 46th annual meeting of the American Society of Clinical Oncology (2010): focus on supportive care issues related to lung cancer.
Boehmer L; Waqar S; Butler S; Sezhiyan A; Govindan R
J Thorac Oncol; 2011 Mar; 6(3):645-9. PubMed ID: 21270665
[TBL] [Abstract][Full Text] [Related]
3. Summary of presentations from the 46th Annual Meeting of the American Society of Clinical Oncology (2010) focus on tumor biology and biomarkers related to lung cancer.
Subramanian J; Corrales L; Soulieres D; Morgensztern D; Govindan R
J Thorac Oncol; 2011 Feb; 6(2):399-403. PubMed ID: 21206384
[TBL] [Abstract][Full Text] [Related]
4. Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology.
J Clin Oncol; 1997 Aug; 15(8):2996-3018. PubMed ID: 9256144
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in lung cancer: summary of presentations from the 45th annual meeting of the American Society of Clinical Oncology (2009).
Goodgame B; Stinchcombe TE; Simon G; Wozniak A; Govindan R
J Thorac Oncol; 2009 Oct; 4(10):1293-300. PubMed ID: 20197737
[TBL] [Abstract][Full Text] [Related]
6. Biomarker testing in advanced non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.
Felip E; Concha Á; de Castro J; Gómez-Román J; Garrido P; Ramírez J; Isla D; Sanz J; Paz-Ares L; López-Ríos F
Clin Transl Oncol; 2015 Feb; 17(2):103-12. PubMed ID: 25351175
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers in Non-Small Cell Lung Cancer: Perspectives of Individualized Targeted Therapy.
Aoki MN; Amarante MK; de Oliveira CEC; Watanabe MAE
Anticancer Agents Med Chem; 2018; 18(15):2070-2077. PubMed ID: 30147015
[TBL] [Abstract][Full Text] [Related]
8. Application of proteomics in non-small-cell lung cancer.
Cho WC
Expert Rev Proteomics; 2016; 13(1):1-4. PubMed ID: 26577456
[TBL] [Abstract][Full Text] [Related]
9. Updates in non-small cell lung cancer--insights from the 2009 45th annual meeting of the American Society of Clinical Oncology.
Mirshahidi HR; Hsueh CT
J Hematol Oncol; 2010 May; 3():18. PubMed ID: 20433767
[TBL] [Abstract][Full Text] [Related]
10. Lung Cancer Highlights from ASCO 2005.
Belvedere O; Grossi F
Oncologist; 2006 Jan; 11(1):39-50. PubMed ID: 16401712
[TBL] [Abstract][Full Text] [Related]
11. Crizotinib in patients with anaplastic lymphoma kinase-positive advanced non-small cell lung cancer versus chemotherapy as a first-line treatment.
Zhou J; Zheng J; Zhang X; Zhao J; Zhu Y; Shen Q; Wang Y; Sun K; Zhang Z; Pan Z; Shen Y; Zhou J
BMC Cancer; 2018 Jan; 18(1):10. PubMed ID: 29298713
[TBL] [Abstract][Full Text] [Related]
12. Recent issues in first-line treatment of advanced non-small-cell lung cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology.
Gridelli C; Ardizzoni A; Douillard JY; Hanna N; Manegold C; Perrone F; Pirker R; Rosell R; Shepherd FA; De Petris L; Di Maio M; de Marinis F
Lung Cancer; 2010 Jun; 68(3):319-31. PubMed ID: 20036027
[TBL] [Abstract][Full Text] [Related]
13. A multicenter survey of first-line treatment patterns and gene aberration test status of patients with unresectable Stage IIIB/IV nonsquamous non-small cell lung cancer in China (CTONG 1506).
Zhou Q; Song Y; Zhang X; Chen GY; Zhong DS; Yu Z; Yu P; Zhang YP; Chen JH; Hu Y; Feng GS; Song X; Shi Q; Yang LL; Zhang PH; Wu YL
BMC Cancer; 2017 Jul; 17(1):462. PubMed ID: 28673332
[TBL] [Abstract][Full Text] [Related]
14. Treatment of Elderly Patients With Non-Small-Cell Lung Cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology.
Gridelli C; Balducci L; Ciardiello F; Di Maio M; Felip E; Langer C; Lilenbaum RC; Perrone F; Senan S; de Marinis F
Clin Lung Cancer; 2015 Sep; 16(5):325-33. PubMed ID: 25862554
[TBL] [Abstract][Full Text] [Related]
15. Guidelines for biomarker testing in advanced non-small-cell lung cancer. A national consensus of the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP).
Garrido P; de Castro J; Concha Á; Felip E; Isla D; López-Ríos F; Paz-Ares L; Ramírez J; Sanz J; Gómez JJ
Clin Transl Oncol; 2012 May; 14(5):338-49. PubMed ID: 22551539
[TBL] [Abstract][Full Text] [Related]
16. [New developments in treatment of non-small cell lung cancer].
Reinmuth N; Gröschel A; Reck M
Pneumologie; 2013 Nov; 67(11):634-8. PubMed ID: 24198238
[TBL] [Abstract][Full Text] [Related]
17. Prognostic markers in resectable non-small cell lung cancer.
Strauss GM
Hematol Oncol Clin North Am; 1997 Jun; 11(3):409-34. PubMed ID: 9209903
[TBL] [Abstract][Full Text] [Related]
18. [Changes in the diagnostic and therapeutic strategies of non-small cell lung cancer].
Ostoros G; Döme B; Strausz J; Tímár J
Magy Onkol; 2010 Jun; 54(2):137-43. PubMed ID: 20576590
[TBL] [Abstract][Full Text] [Related]
19. Quality indicators in cancer care: development and implementation for improved health outcomes in non-small-cell lung cancer.
Lennes IT; Lynch TJ
Clin Lung Cancer; 2009 Sep; 10(5):341-6. PubMed ID: 19808192
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in lung cancer: summary of presentations from the 47 th annual meeting of the American Society of Clinical Oncology (ASCO) 2011.
Subramanian J; Waqar SN; Morgensztern D; Govindan R
J Thorac Oncol; 2012 Jan; 7(1):260-5. PubMed ID: 22173665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
